Skip to main content

Table 1 Baseline Characteristics of Participants in the Victory Trial by Source(s) of Follow-up Smoking Status (N = 5123). Values presented are n (%) or mean, tandard deviation and median (interquartile range) for continuous variables

From: Validating the use of veterans affairs tobacco health factors for assessing change in smoking status: accuracy, availability, and approach

Variable p-value1
  Full Study Population
N = 5123
Both Follow-up Survey and Health Factor Data
N = 1713
Follow-Up Survey Data Only
N = 1594
Health Factor Data Only
N = 790
Neither Follow-up Survey nor Health Factor Data
N = 1026
 
Age in years 56.2 ± 12.0, 58 (12) 58.1 ± 9.6,
59 (11)
57.5 ± 11.5, 60 (13) 54.0 ± 12.6, 56 (15) 52.5 ± 14.5,
55 (19)
<.001
Age ≥ 65 years old 1094 (21.4%) 374 (21.8%) 402 (25.2%) 134 (17.0%) 184 (17.9%) <.001
Male gender 4830 (94.3%) 1613 (94.2%) 1518 (95.2%) 741 (93.8%) 958 (93.4%) .201
Race       <.001
White
Black
Other
2970 (58.0%)
1418 (27.7%)
735 (14.4%)
1105 (64.5%)
421 (24.6%)
187 (10.9%)
843 (52.9%)
485 (30.4%)
266 (16.7%)
488 (61.8%)
219 (27.7%)
83 (10.5%)
534 (52.1%)
293 (28.6%)
199 (19.4%)
 
Smoking-related respiratory disease 960 (18.7%) 354 (20.7%) 294 (18.4%) 134 (17.0%) 178 (17.4%) .066
Any mental illness 2465 (48.1%) 789 (46.1%) 736 (46.2%) 403 (51.0%) 537 (52.3%) .002
Breakdown of diagnoses out of those with at least 1 mental illness:
Depression
PTSD
Anxiety
Substance Use Disorder
Serious Mental Illness
Other
1124 (45.6%)
466 (18.9%)
511 (20.7%)
1029 (41.7%)
367 (14.9%)
869 (35.3%)
347 (44.0%)
123 (15.6%)
177 (22.4%)
330 (41.8%)
111 (14.1%)
284 (36.0%)
338 (45.9%)
154 (20.9%)
119 (16.2%)
325 (44.2%)
104 (14.1%)
243 (33.0%)
175 (43.4%)
77 (19.1%)
95 (23.6%)
157 (39.0%)
76 (18.9%)
159 (39.5%)
264 (49.2%)
112 (20.9%)
120 (22.4%)
217 (40.4%)
76 (14.2%)
183 (34.1%)
.223
.030
.004
.328
.112
.155
Hospitalized in the past year 543 (10.6%) 188 (11.0%) 142 (8.9%) 104 (13.2%) 109 (10.6%) .014
Number of hospitalizations in the prior year out of those with at least 1 1.67 ± 1.39, 1.00 (1.00) 1.52 ± 0.95, 1.00 (1.00) 1.56 ± 1.05, 1.00 (1.00) 1.76 ± 1.29, 1.00 (1.00) 1.97 ± 2.23, 1.00 (1.00) 0.541
Charlson comorbidity index 1.03 ± 1.44, 1.00 (2.00) 1.09 ± 1.42, 1.00 (2.00) 0.99 ± 1.38, 1.00 (1.00) 1.09 ± 1.52, 1.00 (2.00) 0.97 ± 1.52,
0.00 (1.00)
<.001
Site       <.001
A 1173 (22.9%) 620 (36.2%) 107 (6.7%) 336 (42.5%) 110 (10.7%)  
B 1384 (27.0%) 492 (28.7%) 447 (28.0%) 197 (24.9%) 248 (24.2%)  
C 1301 (25.4%) 22 (1.3%) 773 (48.5%) 25 (3.2%) 481 (46.9%)  
D 1265 (24.7%) 579 (33.8%) 267 (16.8%) 232 (29.4%) 187 (18.2%)  
  1. Pearson Chi-square test was used for categorical variables and Kruskal-Wallis rank sum test was used for continuous variables to assess if there were any group differences